Biotech Startups
10,056 companies tagged Biotech, with their investors and founders.
PNP Therapeutics is a clinical-stage biopharmaceutical company developing Gedeptin, a platform technology for cancer treatment that programs tumors to generate their own chemotherapy through a patented enzyme and prodrug system. The company targets patients with solid tumors including prostate, breast, colon, lung, brain, melanoma, pancreas, ovarian, and kidney cancers.
0 investors
POET is the world leader in bioethanol production, using agricultural resources to create renewable bioproducts including bioethanol, high-quality food and feed products, purified alcohol, captured carbon dioxide, corn oil-based asphalt solutions, engineering and construction services, and logistics support.
0 investors
0 investors
Polybiomics develops a live cell analysis platform that measures multiple phenotypes and functions of cells simultaneously and continuously without disrupting them or their 3D environments. The system combines a bioinstrument, consumable, and the PolyData analytics engine with AI to interpret multimodal datasets for research, pharmaceutical, biomanufacturing, and clinical workflows.
0 investors
0 investors
0 investors
PolyVascular develops a polymer-based transcatheter pulmonary heart valve for pediatric patients with congenital heart conditions. The medical device company focuses on providing durable, minimally invasive valve replacements for children.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Praeventix is an early-stage biopharmaceutical company developing serotonergic (5-HT7 receptor) therapeutics, with a lead topical candidate PRA-523 aimed at treating chronic pruritus in conditions such as atopic dermatitis. It is also researching 5-HT7 modulators for inflammatory bowel disease and cocaine use disorder.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
PreciseDx develops molecular pathology diagnostic tools for cancer care, combining anatomical pathology with molecular and systems biology to enable precise diagnosis and treatment planning. The company's flagship product serves pathologists and oncologists seeking data-driven insights for patient risk stratification and personalized cancer care.
0 investors
Precision Biologics develops therapeutic and diagnostic products for cancer patients. The company operates in the oncology biotech space in the United States.
0 investors
Precision Epigenomics develops EPISEEK, a blood-based multi-cancer early detection test that analyzes hypermethylated DNA loci to identify DNA changes linked to over 60 cancer types before symptoms appear. The test serves higher-risk individuals, health-conscious people aged 45+, healthcare providers, and wellness programs, with lab analysis performed at a CAP-accredited, CLIA-certified lab.
0 investors